Omega-3 for Peri- and Postmenopausal Depression

Completed · Not applicable

Conditions studied: Depression

In brief

The purpose of this study is to determine if an eight-week intervention with omega-3 fatty acids significantly reduces depressive symptoms in symptomatic peri- and postmenopausal women. We hypothesize that an eight-week trial with omega-3 fatty acids promotes significant improvement in depression symptoms in peri- and postmenopausal women.

Key facts

Study ID

NCT00825994

Run by

Massachusetts General Hospital

People needed

31

Starts

2008-11-01

Expected to finish

2009-06-01

Last updated by the study team

2014-08-21

Who can join

Age: 40 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women age 40 and older in the peri- or postmenopausal period, as defined in Soules et al. 2001
• Meet criteria for Major Depressive Disorder on the MINI (Mini-International Neuropsychiatric Interview)
• Score of 18 or greater on MADRS (Montgomery-Asberg Depression Rating Scale) at screening visit
• Do not meet criteria for placebo response during placebo run-in phase; placebo response is defined as a > 50% decrease in MADRS from screening to end of placebo run-in phase
• Willing to receive treatment on an outpatient basis
• Presence of general good health

You may not qualify if…

• Currently pregnant, trying to conceive, or breastfeeding
• Treatment with an antidepressant medication currently or in the past 1 month
• Treatment with hormone replacement therapy currently or in the past 1 month
• Treatment with Omega-3 supplements currently or in the past 1 month
• Use of birth control pills currently or in the past 1 month
• Presence of suicidal ideation
• Meet criteria for current or within the past month for panic disorder, obsessive compulsive disorder (OCD), psychosis, mania or hypomania, as assessed by the MINI
• Diagnosis of treatment resistant Major Depressive Disorder, defined as patients who have been treated with two or more therapeutic courses of antidepressant medication without remission of symptoms for the current episode of depression, as assessed by the MINI
• Any medical condition that would make participation in the study unsafe, as determined by investigator
• Presence of a known allergy to fish or fish oil that would put participant at risk, as determined by a study investigator

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.